Humana, Inc. (NYSE:HUM ) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations James Rechtin - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Conference Call Participants Ann Hynes - Mizuho Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Justin Lake - Wolfe Research David Windley - Jefferies A.J. Rice - UBS Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Ben Hendrix - RBC Capital Markets Stephen Baxter - Wells Fargo Scott Fidel - Stephens Lance Wilkes - Bernstein Michael Ha - Baird Jessica Tassan - Piper Sandler John Ransom - Raymond James George Hill - Deutsche Bank Erin Wright - Morgan Stanley Ryan Langston - TD Cowen Operator Good day, and thank you for standing by.
The headline numbers for Humana (HUM) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Humana (HUM) came out with quarterly earnings of $6.96 per share, beating the Zacks Consensus Estimate of $5.89 per share. This compares to earnings of $8.94 per share a year ago.
Humana Inc.'s stock HUM was down 3.5% in premarket trading on Wednesday after the health insurance giant said its profit fell, although its adjusted earnings beat analyst expectations. Humana said its second-quarter net income dropped to $918 million, or $5.62 a share, from $1.26 billion, or $7.66 a share in the year-ago quarter.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humana securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.